title: The influence of mycophenolate mofetil and azathioprine on the same cadaveric donor renal transplantation.
abstract: In order to evaluate whether immunosuppressive agents such as mycophenolate mofetil (MMF) and azathioprine would differently influence the outcome of the renal transplants, we prospectively analyzed the incidence of acute rejection episodes, cytomegalovirus infection within the first 6 months following renal transplantation and 5 yr graft survival rate after minimizing influences of donor factors by grafting the same cadaveric donor kidney. There was no significant difference in sex, HLA mismatch, cold ischemic time, and patients' weight between the two groups. Contrary to the previous studies which demonstrated that MMF could lower the incidence of acute rejection episodes and improved graft survival rate, the two groups showed no significant difference in the incidence of acute rejection episodes and 5-yr graft survival rate as well. This discrepancy in these results might explain that donor factors could be important to cadaveric renal transplantation. Thus, we suggest that the influences of donor factors should be considered in further clinical studies of cadaveric renal transplantation.
authors.affiliation: Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
authors.forename: Jae Won
authors.initials: JW
authors.lastname: Joh
authors.forename: Hwan Hyo
authors.initials: HH
authors.lastname: Lee
authors.forename: Dae Sung
authors.initials: DS
authors.lastname: Lee
authors.forename: Kwang Woong
authors.initials: KW
authors.lastname: Lee
authors.forename: Suk Koo
authors.initials: SK
authors.lastname: Lee
authors.forename: Sung Joo
authors.initials: SJ
authors.lastname: Kim
mesh_terms: D000017:ABO Blood-Group System; D000328:Adult; D001379:Azathioprine / Q000494:pharmacology*; D001835:Body Weight; D002102:Cadaver; D003587:Cytomegalovirus / Q000378:metabolism; D003586:Cytomegalovirus Infections / Q000378:metabolism; D005260:Female; D006084:Graft Rejection; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D016130:Immunophenotyping; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007511:Ischemia; D007674:Kidney Diseases / Q000401:mortality / Q000628:therapy; D016030:Kidney Transplantation / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology*; D011446:Prospective Studies; D013997:Time Factors; D014019:Tissue Donors; D016896:Treatment Outcome
chemical_list: D000017:ABO Blood-Group System; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D001379:Azathioprine
references.citation: Transplantation. 1999 Dec 27;68(12):1842-6
references.pmid: 10628761
references.citation: Transplantation. 2000 Mar 15;69(5):790-4
references.pmid: 10755527
references.citation: Nephrol Dial Transplant. 2003 Oct;18(10):2141-6
references.pmid: 13679493
references.citation: Lancet. 1995 May 27;345(8961):1321-5
references.pmid: 7752752
references.citation: J Am Soc Nephrol. 1999 Jun;10(6):1317-23
references.pmid: 10361871
references.citation: Transplantation. 1996 Apr 15;61(7):1029-37
references.pmid: 8623181
references.citation: Transplantation. 1997 Jan 15;63(1):39-47
references.pmid: 9000658
references.citation: Nephron. 1997;76(4):392-9
references.pmid: 9274835
references.citation: Transplantation. 1998 Jan 27;65(2):219-23
references.pmid: 9458018
references.citation: Transplantation. 1995 Aug 15;60(3):225-32
references.pmid: 7645033